A combination therapy of ingredients from TCM for the prevention and treatment of gastric cancer by targeting HER2/ PD-L1

• Main Authors: Ling Li (Author), Jia-wei Li (Author), Xiao-jie Jin (Author), Cheng-hao Li (Author), Jun-jie Li (Author), Ming Fang (Author), Lu Qiu (Author), Si-yu Wang (Author), Wei Chu (Author), Yong-qi Liu (Author)
• Format: Book
• Published: Elsevier, 2021-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Gastric cancer (GC) is a globally important disease. Targeted therapies licensed to treat gastric cancer include trastuzumab, which targets HER2, and nivolumab or pembrolizumab, which block PD-1/PD-L1. The main challenge of tumor molecule-targeted drugs is resistance. Based on the multicomponent and...